1. Hypoglycemic benefit and potential mechanism of a polysaccharide from Hericium erinaceus in streptozotoxin-induced diabetic rats
- Author
-
He-Nan Zhang, Jing-Kun Yan, Yan Yang, Wu-Dan Cai, Zhi-Chao Ding, and Yao-Yao Wang
- Subjects
0106 biological sciences ,Antioxidant ,medicine.medical_treatment ,Bioengineering ,Pharmacology ,01 natural sciences ,Applied Microbiology and Biotechnology ,Biochemistry ,Lipid peroxidation ,03 medical and health sciences ,chemistry.chemical_compound ,010608 biotechnology ,Diabetes mellitus ,medicine ,Glycogen synthase ,030304 developmental biology ,0303 health sciences ,biology ,Kinase ,business.industry ,Lipid metabolism ,medicine.disease ,biology.organism_classification ,chemistry ,Protein kinase B signaling ,biology.protein ,business ,Hericium erinaceus - Abstract
In this study, the hypoglycemic effect and possible mechanism of a polysaccharide, HEP-C, isolated from the fruit body of Hericium erinaceus were evaluated in streptozotoxin (STZ)-induced diabetic rats. Compared with the untreated STZ-induced diabetic rats, the supplements with HEP-C (150 and 300 mg/kg body weight [BW]) could significantly and dose-dependently relieve BW loss and organ injures, reduce fasting blood glucose, enhance glucose tolerance, alleviate hepatic function and serum lipid metabolism, elevate antioxidant enzyme activities, and suppress lipid peroxidation, which contributed to its potent hypoglycemic benefit. Liver histopathological observation revealed that HEP-C could effectively attenuate the deteriorated hepatic lesions in STZ-induced diabetic rats. HEP-C with potent hypoglycemic effect positively mediated glycogen synthesis by activating the phosphatidylinositol-3-kinase/protein kinase B signaling pathway. In summary, these results suggested that HEP-C, as a new dietary functional food or therapeutic agent, exhibited great potential for the prevention and treatment of diabetes mellitus and its complications.
- Published
- 2020